NADPH oxidase inhibitor, apocynin, improves renal glutathione status in Zucker diabetic fatty rats: A comparison with melatonin

Chemico-Biological Interactions

Volumn 218, Issue , 2014, Pages 12-19

  Winiarska, Katarzyna ^a   Focht, Dorota ^a   Sierakowski, Bartosz ^a   Lewandowski, Krystian ^a   Orlowska, Marta ^a   Usarek, Michal ^a  

^a UNIVERSITY OF WARSAW   (Poland)

Author keywords

Apocynin; Glutathione; Kidney; Melatonin; NADPH oxidase; ZDF rat

Indexed keywords

APOCYNIN; CREATININE; DRINKING WATER; GLUCOSE; GLUTAMATE CYSTEINE LIGASE; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HYDROXYL RADICAL; MELATONIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; UREA;

ALBUMINURIA; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG MECHANISM; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; GLUTATHIONE METABOLISM; KIDNEY CORTEX; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATION REDUCTION STATE; RAT; UREA BLOOD LEVEL; ZUCKER DIABETIC FATTY RAT;

APOCYNIN; GLUTATHIONE; KIDNEY; MELATONIN; NADPH OXIDASE; ZDF RAT;

ACETOPHENONES; ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS, EXPERIMENTAL; ENZYME INHIBITORS; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HYDROXYL RADICAL; MALE; MELATONIN; NADPH OXIDASE; OBESITY; RATS; RATS, ZUCKER;

EID: 84900854397     PISSN: 00092797     EISSN: 18727786     Source Type: Journal    
DOI: 10.1016/j.cbi.2014.04.005     Document Type: Article

References (51)

1. S. Altenhöfer, P.W. Kleikers, K.A. Radermacher, P. Scheurer, J.J. Rob Hermans, P. Schiffers, H. Ho, K. Wingler, and H.H. Schmidt The NOX toolbox: validating the role of NADPH oxidases in physiology and disease Cell. Mol. Life Sci. 69 2012 2327 2343
2. B. Lassègue, A. San Martín, and K.K. Griendling Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system Circ. Res. 110 2012 1364 1390
3. R.C. Stanton Oxidative stress and diabetic kidney disease Curr. Diab. Rep. 11 2011 330 336
4. M. Sedeek, A.C. Montezano, R.L. Hebert, S.P. Gray, E. Di Marco, J.C. Jha, M.E. Cooper, K. Jandeleit-Dahm, E.L. Schiffrin, J.L. Wilkinson-Berka, and R.M. Touyz Oxidative stress, Nox isoforms and complications of diabetes - potential targets for novel therapies J. Cardiovasc. Transplant. Res. 5 2012 509 518
5. A. Tojo, K. Asaba, and M.L. Onozato Suppressing renal NADPH oxidase to treat diabetic nephropathy Expert Opin. Ther. Targets 11 2007 1011 1018
6. J. Stefanska, and R. Pawliczak Apocynin: molecular aptitudes Mediators Inflamm. 2008 2008 106507
7. M.S. Petronio, M.L. Zeraik, L.M. Fonseca, and V.F. Ximenes Apocynin: chemical and biophysical properties of a NADPH oxidase inhibitor Molecules 18 2013 2821 2839
8. J. Yu, M. Weïwer, R.J. Linhardt, and J.S. Dordick The role of the methoxyphenol apocynin, a vascular NADPH oxidase inhibitor, as a chemopreventative agent in the potential treatment of cardiovascular diseases Curr. Vasc. Pharmacol. 6 2008 204 217
9. A. Simonyi, P. Serfozo, T.M. Lehmidi, J. Cui, Z. Gu, D.B. Lubahn, A.Y. Sun, and G.Y. Sun The neuroprotective effects of apocynin Front. Biosci. (Elite Ed.) 4 2012 2183 2193
10. C. Riganti, C. Costamagna, A. Bosia, and D. Gigo The NADPH oxidase inhibitor apocynin (acetovanillone) induces oxidative stress Toxicol. Appl. Pharmacol. 212 2006 179 187
11. L.R. Castor, K.A. Locatelli, and V.F. Ximenes Pro-oxidant activity of apocynin radical Free Radic. Biol. Med. 48 2010 1636 1643
12. H.J. Forman, H. Zhang, and A. Rinna Glutathione: overview of its protective roles, measurement, and biosynthesis Mol. Aspects. Med. 30 2009 1 12
13. R. Franco, O.J. Schoneveld, A. Pappa, and M.I. Panayiotidis The central role of glutathione in the pathophysiology of human diseases Arch. Physiol. Biochem. 113 2007 234 258
14. N. Ballatori, S.M. Krance, S. Notenboom, S. Shi, K. Tieu, and C.L. Hammond Glutathione dysregulation and the etiology and progression of human diseases Biol. Chem. 390 2009 191 214
15. P.N. Chander, O. Gealekman, S.V. Brodsky, S. Elitok, A. Tojo, M. Crabtree, S.S. Gross, and M.S. Goligorsky Nephropathy in Zucker diabetic fat rat is associated with oxidative and nitrosative stress: prevention by chronic therapy with a peroxynitrite scavenger ebselen J. Am. Soc. Nephrol. 15 2004 2391 2403
16. A. Chatzigeorgiou, A. Halapas, K. Kalafatakis, and E. Kamper The use of animal models in the study of diabetes mellitus In Vivo 23 2009 245 258
17. J.E. Toblli, G. Cao, J.F. Giani, M.C. Muñoz, M. Angerosa, and F.P. Dominici Long-term treatment with nebivolol attenuates renal damage in Zucker diabetic fatty rats J. Hypertens. 29 2011 1613 1623
18. K. Winiarska, T. Fraczyk, D. Malinska, J. Drozak, and J. Bryla Melatonin attenuates diabetes-induced oxidative stress in rabbits J. Pineal Res. 40 2006 168 176
19. R.A. Derlacz, M. Sliwinska, A. Piekutowska, K. Winiarska, J. Drozak, and J. Bryla Melatonin is more effective than taurine and 5-hydroxytryptophan against hyperglycemia-induced kidney-cortex tubules injury J. Pineal Res. 42 2007 203 209
20. F. Luchetti, B. Canonico, M. Betti, M. Arcangeletti, F. Pilolli, M. Piroddi, L. Canesi, S. Papa, and F. Galli Melatonin signaling and cell protection function FASEB J. 24 2010 3603 3624
21. A. Korkmaz, S. Ma, T. Topal, S. Rosales-Corral, D.X. Tan, and R.J. Reiter Glucose: a vital toxin and potential utility of melatonin in protecting against the diabetic state Mol. Cell. Endocrinol. 349 2012 128 137
22. P. Lardone, N. Alvarez-Sánchez, J. Guerrero, and A. Carrillo-Vico Melatonin and glucose metabolism: clinical relevance Curr. Pharm. Des. 2013 [Epub ahead of print]
23. Y.I. Chirino, D.J. Sánchez-González, C.M. Martínez-Martínez, C. Cruz, and J. Pedraza-Chaverri Protective effects of apocynin against cisplatin-induced oxidative stress and nephrotoxicity Toxicology 245 2008 18 23
24. H. Ha, M.R. Yu, and K.H. Kim Melatonin and taurine reduce early glomerulopathy in diabetic rats Free Radic. Biol. Med. 26 1999 944 950
25. R. Jarzyna, A. Kiersztan, O. Lisowa, and J. Bryla The inhibition of gluconeogenesis by chloroquine contributes to its hypoglycaemic action Eur. J. Pharmacol. 428 2001 381 388
26. K. Winiarska, M. Grabowski, and M.K. Rogacki Inhibition of renal gluconeogenesis contributes to hypoglycaemic action of NADPH oxidase inhibitor, apocynin Chem. Biol. Interact. 189 2011 119 126
27. L.I. McLellan, L.A. Kerr, A.D. Cronshaw, and J.D. Hayes Regulation of mouse glutathione S-transferases by chemoprotectors. Molecular evidence for the existence of three distinct alpha-class glutathione S-transferase subunits, Ya1, Ya2, and Ya3, in mouse liver Biochem. J. 276 1991 461 469
28. Y. Chen, P.S. Gill, and W.J. Welch Oxygen availability limits renal NADPH-dependent superoxide production Am. J. Physiol. Ren. Physiol. 289 2005 749 753
29. F.C. Cheng, J.F. Jen, and T.H. Tsai Hydroxyl radical in living systems and its separation methods J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 781 2002 481 496
30. Y. Gorin, K. Block, J. Hernandez, B. Bhandari, B. Wagner, J.L. Barnes, and H.E. Abboud Nox4 NAD(P)H oxidase mediates hypertrophy and fibronectin expression in the diabetic kidney J. Biol. Chem. 280 2005 39616 39626
31. H.U. Bergmeyer Methods in Enzymatic Analysis 1983 Verlag Chemie GmbH Weinheim-Basel
32. D.E. Paglia, and W.N. Valentine Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase J. Lab. Clin. Med. 70 1967 158 169
33. D. Hamilton, J.H. Wu, M. Alaoui-Jamali, and G. Batist A novel missense mutation in the gamma-glutamylcysteine synthetase catalytic subunit gene causes both decreased enzymatic activity and glutathione production Blood 102 2003 725 730
34. H.G. Kim, S.M. Hong, S.J. Kim, H.J. Park, H.I. Jung, Y.Y. Lee, J.S. Moon, H.W. Lim, E.H. Park, and C.J. Lim Age-related changes in the activity of antioxidant and redox enzymes in rats Mol. Cells 16 2003 278 284
35. 2 on the rate of ammonia formation in blood Eur. J. Clin. Chem. Clin. Biochem. 30 1992 867 869
36. M. Michalik, I. Biedermann, T. Lietz, and J. Bryla Recovery of impaired gluconeogenesis in kidney cortex tubules of gentamicin-treated rabbits Pharmacol. Res. 23 1991 259 269
37. Y. Hiraku, M. Murata, and S. Kawanishi Determination of intracellular glutathione and thiols by high performance liquid chromatography with a gold electrode at the femtomole level: comparison with a spectroscopic assay Biochim. Biophys. Acta 1570 2002 47 52
38. M.M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal. Biochem. 72 1976 248 254
39. T. Nakao, H. Morita, K. Maemura, E. Amiya, T. Inajima, Y. Saito, M. Watanabe, I. Manabe, M. Kurabayashi, R. Nagai, and I. Komuro Melatonin ameliorates Angiotensin II-induced vascular endothelial damage via its antioxidative properties J. Pineal Res. 2013 10.1111/jpi.12071 [Epub ahead of print]
40. R.A. Afonso, A.B. Fernandes, C. Santos, D. Ligeiro, R.T. Ribeiro, I.S. Lima, R.S. Patarrao, P.A. Videira, J. Caldeira, and M.P. Macedo Postprandial insulin resistance in Zucker diabetic fatty rats is associated with parasympathetic-nitric oxide axis deficiencies J. Neuroendocrinol. 24 2012 1346 1355
41. E. Lubos, J. Loscalzo, and D.E. Handy Glutathione peroxidase-1 in health and disease: from molecular mechanisms to therapeutic opportunities Antioxid. Redox. Signal. 15 2011 1957 1997
42. 1 receptor and NAD(P)H oxidase mediate angiotensin II-stimulated antioxidant enzymes and mitogen-activated protein kinase activity in the rat hypothalamus J. Renin Angiotensin Aldosterone Syst. 11 2010 234 242
43. T.S. Lapperre, L.A. Jimenez, F. Antonicelli, E.M. Drost, P.S. Hiemstra, J. Stolk, W. MacNee, and I. Rahman Apocynin increases glutathione synthesis and activates AP-1 in alveolar epithelial cells FEBS Lett. 443 1999 235 239
44. S.S. Barbieri, V. Cavalca, S. Eligini, M. Brambilla, A. Caiani, E. Tremoli, and S. Colli Apocynin prevents cyclooxygenase 2 expression in human monocytes through NADPH oxidase and glutathione redox-dependent mechanisms Free Radic. Biol. Med. 37 2004 156 165
45. N. Tian, R.S. Moore, W.E. Phillips, L. Lin, S. Braddy, J.S. Pryor, R.L. Stockstill, M.D. Hughson, and R.D. Manning Jr. NADPH oxidase contributes to renal damage and dysfunction in Dahl salt-sensitive hypertension Am. J. Physiol. Regul. Integr. Comp. Physiol. 295 2008 R1858 R1865
46. R. Meng, D.L. Zhu, Y. Bi, D.H. Yang, and Y.P. Wang Anti-oxidative effect of apocynin on insulin resistance in high-fat diet mice Ann. Clin. Lab. Sci. 41 2011 236 243
47. K. Asaba, A. Tojo, M.L. Onozato, A. Goto, M.T. Quinn, T. Fujita, and C.S. Wilcox Effects of NADPH oxidase inhibitor in diabetic nephropathy Kidney Int. 67 2005 1890 1898
48. S.M. Nam, M.Y. Lee, J.H. Koh, J.H. Park, J.Y. Shin, Y.G. Shin, S.B. Koh, E.Y. Lee, and C.H. Chung Effects of NADPH oxidase inhibitor on diabetic nephropathy in OLETF rats: the role of reducing oxidative stress in its protective property Diab. Res. Clin. Pract. 83 2009 176 182
49. V. Thallas-Bonke, M.T. Coughlan, L.A. Bach, M.E. Cooper, and J.M. Forbes Preservation of kidney function with combined inhibition of NADPH oxidase and angiotensin-converting enzyme in diabetic nephropathy Am. J. Nephrol. 32 2010 73 82
50. I. Bazwinsky-Wutschke, L. Bieseke, E. Mühlbauer, and E. Peschke Influence of melatonin receptor signalling on parameters involved in blood glucose regulation J. Pineal Res. 2013 10.1111/jpi.12100 [Epub ahead of print]
51. A. Agil, I. Rosado, R. Ruiz, A. Figueroa, N. Zen, and G. Fernández-Vázquez Melatonin improves glucose homeostasis in young Zucker diabetic fatty rats J. Pineal Res. 52 2012 203 210